Clearance of antiphospholipid antibodies in pregnancies treated with heparin

Obstetrics and Gynecology

Volumn 97, Issue 3, 2001, Pages 394-398

  Masamoto, Hitoshi ^a   Toma, Takashi ^a   Sakumoto, Kaoru ^a   Kanazawa, Koji ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; HUMAN; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS; THROMBOSIS;

ABORTION, SPONTANEOUS; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 0035120293     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)01180-7     Document Type: Article

References (23)

1. Anticardiolipin antibodies. Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
2. The antiphospholipid syndrome: Ten years on
3. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction
4. Antiphospholipid antibodies in pregnancy: Prevalence and clinical associations
5. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies
6. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast
7. Anticardiolipin antibodies induce pregnancy failure by impairing embryonic implantation
8. Placental changes in a first trimester abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: A case report and review of the literature
9. Fetal survival after prednisone suppression of maternal lupus-anticoagulant
10. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies
11. Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome
12. Antiphospholipid antibodies in predicting adverse pregnancy outcome
13. Marked variation in antiphospholipid antibodies during pregnancy: Relationships to pregnancy outcome
14. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies
15. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
16. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
17. Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody
18. Intravenous immunoglobulin infusion therapy in women with recurrent spontaneous abortions of immune etiologies
19. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
20. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients
21. Hemorrhagic complication of anticoagulation during pregnancy in a woman with lupus anticoagulant
22. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss
23. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin